William Blair Estimates Certara’s Q1 Earnings (NASDAQ:CERT)

Certara, Inc. (NASDAQ:CERT) – Equities researchers at William Blair raised their Q1 2025 EPS estimates for Certara in a report released on Monday, April 14th. William Blair analyst M. Smock now anticipates that the company will post earnings of $0.07 per share for the quarter, up from their prior estimate of $0.06. William Blair currently has a “Market Perform” rating on the stock. The consensus estimate for Certara’s current full-year earnings is $0.28 per share. William Blair also issued estimates for Certara’s Q4 2025 earnings at $0.07 EPS.

CERT has been the subject of a number of other reports. TD Cowen assumed coverage on Certara in a report on Thursday, February 27th. They issued a “buy” rating and a $16.00 price target for the company. Barclays dropped their target price on shares of Certara from $13.00 to $11.00 and set an “equal weight” rating for the company in a research note on Thursday, April 10th. Stephens reissued an “overweight” rating and set a $17.00 price target on shares of Certara in a research note on Thursday, February 27th. Robert W. Baird raised their price target on shares of Certara from $9.00 to $13.00 and gave the company a “neutral” rating in a report on Friday, April 11th. Finally, KeyCorp upped their price objective on Certara from $15.00 to $18.00 and gave the stock an “overweight” rating in a report on Wednesday. Four equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $15.17.

Certara Trading Up 4.6 %

Shares of CERT opened at $14.15 on Wednesday. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.86 and a current ratio of 2.86. The company has a market cap of $2.28 billion, a price-to-earnings ratio of -70.75, a PEG ratio of 9.29 and a beta of 1.64. The stock has a fifty day moving average price of $11.62 and a two-hundred day moving average price of $11.44. Certara has a 52-week low of $8.64 and a 52-week high of $17.94.

Institutional Investors Weigh In On Certara

A number of institutional investors and hedge funds have recently modified their holdings of CERT. Janney Montgomery Scott LLC acquired a new stake in Certara during the 1st quarter worth $120,000. SG Americas Securities LLC boosted its position in shares of Certara by 350.1% in the 1st quarter. SG Americas Securities LLC now owns 69,727 shares of the company’s stock worth $690,000 after purchasing an additional 54,235 shares during the last quarter. Harbor Capital Advisors Inc. grew its stake in shares of Certara by 16.2% during the first quarter. Harbor Capital Advisors Inc. now owns 20,294 shares of the company’s stock worth $201,000 after purchasing an additional 2,834 shares during the period. Portside Wealth Group LLC bought a new stake in Certara in the first quarter valued at about $104,000. Finally, Kopion Asset Management LLC increased its holdings in Certara by 8.0% in the first quarter. Kopion Asset Management LLC now owns 600,159 shares of the company’s stock valued at $5,942,000 after purchasing an additional 44,516 shares during the last quarter. 73.96% of the stock is owned by institutional investors.

About Certara

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.